Cidara Therapeutics
CDTX
CDTX
58 hedge funds and large institutions have $119M invested in Cidara Therapeutics in 2016 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 26 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
14% more funds holding
Funds holding: 51 → 58 (+7)
3.42% more ownership
Funds ownership: 0% → 3.42% (+3.4%)
Holders
58
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$5.15M | |
| 2 | +$4.12M | |
| 3 | +$3.09M | |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$1.66M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.53M |
Top Sellers
| 1 | -$240K | |
| 2 | -$229K | |
| 3 | -$172K | |
| 4 |
TG
TLP Group
Evanston,
Illinois
|
-$62K |
| 5 |
RhumbLine Advisers
Boston,
Massachusetts
|
-$33.7K |